Clinical Trial

Prednisolone Acetate Eye Drops for Pain Intervention in Second Eye Cataract Surgery

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the efficacy, safety, and potential mechanisms of prednisolone acetate eye drops for pain management in patients undergoing second-eye surgery for age-related cataracts. Researchers will compare prednisolone acetate eye drops to sodium hyaluronate eye drops to see if prednisolone acetate eye drops work to relieve intraoperative and postoperative pain during second-eye cataract surgery. Participants will: 1. Receive prednisolone acetate eye drops or sodium hyaluronate eye drop four drops within 2 hours before cataract surgery 2. Finish cataract surgery and routine postoperative follow-up 3. Pain questionnaire completed after cataract surgery
Trial Details
NCT Number NCT06614348
Lead Sponsor Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Conditions Age Related Cataract, Pain Management During Cataract Surgery
Enrollment 70 participants
Start Date 2024-10-08
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-26